Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma
暂无分享,去创建一个
Eckart Meese | Andreas Keller | Hans-Peter Lenhof | Nicole Ludwig | Petra Leidinger | Hans-Peter Lenhof | A. Keller | P. Leidinger | N. Ludwig | E. Meese | H. Huwer | J. Hamacher | Stefanie Rheinheimer | Stefanie Rheinheimer | Jürg Hamacher | Hanno Huwer | Ingo Stehle | Ingo Stehle
[1] J. Jen,et al. Circulating antibodies to p40AIS in the sera of respiratory tract cancer patients , 2000, International Journal of Cancer.
[2] U. Fischer,et al. cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients. , 1997, Human molecular genetics.
[3] Alissa K. Greenberg,et al. Biomarkers for lung cancer: clinical uses , 2007, Current opinion in pulmonary medicine.
[4] A Murray,et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure , 2007, Thorax.
[5] R. Hansen,et al. Antibody pharmacokinetics and pharmacodynamics. , 2004, Journal of pharmaceutical sciences.
[6] Debashis Ghosh,et al. Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.
[7] Arnold J Stromberg,et al. Using protein microarray as a diagnostic assay for non-small cell lung cancer. , 2005, American journal of respiratory and critical care medicine.
[8] S M Hanash,et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] Ping He,et al. Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancer , 2007 .
[10] A. Gazdar,et al. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] D. Bellamy,et al. Role of primary care in early diagnosis and effective management of COPD , 2007, International journal of clinical practice.
[12] Michiaki Mishima,et al. POCKET GUIDE TO COPD DIAGNOSIS, MANAGEMENT, AND PREVENTION A Guide for Health Care Professionals , 2007 .
[13] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[14] W Feiden,et al. PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme , 2001, Oncogene.
[15] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[16] Christina Backes,et al. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Hanash,et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. , 2001, Cancer research.
[18] David H. Johnson,et al. Combined modality therapy in non‐small cell lung cancer , 1995, Current opinion in oncology.
[19] Irina Kusmartseva,et al. Panel of serum biomarkers for the diagnosis of lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] G Sybrecht,et al. Role of amplified genes in the production of autoantibodies. , 1999, Blood.
[21] Eckart Meese,et al. SePaCS—a web-based application for classification of seroreactivity profiles , 2007, Nucleic Acids Res..
[22] T. Nishida,et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. , 2006, Cancer science.
[23] U. Fischer,et al. Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I. , 1997, Human molecular genetics.
[24] Claude E. Shannon,et al. The mathematical theory of communication , 1950 .
[25] Ugur Sahin,et al. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. , 2006, Cancer letters.
[26] M J O'Hare,et al. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. , 2001, Cancer immunity.
[27] A. Stromberg,et al. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[28] A. Stromberg,et al. Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancer , 2004, Proteomics.
[29] Nicole Comtesse,et al. Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma , 2002, International journal of cancer.
[30] U. Fischer,et al. Expression of the gene for hematopoietic cell specific protein is not restricted to cells of hematopoietic origin. , 2005, International journal of molecular medicine.
[31] L. Old,et al. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. , 2004, Cancer immunity.
[32] A. Yamamoto,et al. Detection of auto‐antibodies against L‐myc oncogene products in sera from lung cancer patients , 1996, International journal of cancer.
[33] Sang Joon Kim,et al. A Mathematical Theory of Communication , 2006 .